Outer Membrane Protein Vesicle Vaccines for Meningococcal Disease

Carl E. Frasch, Loek van Alphen, Johan Holst, Jan Poolman, Einar Rosenqvist

Humana Press eBooks · 2003 · 79 citations · 40 references

Concepts

Abstract

Alternative strategies exist for prevention of group B Neisseria meningitidis (meningococcal) disease through vaccination (see Chapters 5 , 8 , 13 , 14 in this volume). However, the most promising approach to date has been the use of outer-membrane vesicle (OMV) vaccines for induction of bactericidal antibodies against cell-surface outer-membrane proteins (OMPs).

References

40